News
Lawmakers start a 30-day special session July 21 to tackle consumable THC, flood dangers, congressional districts, abortion pills and more.
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback